Drug Type Small molecule drug |
Synonyms (6,9,12)-linolenic acid, (6Z,9Z,12Z)-Octadecatrienoic acid, (Z,Z,Z)-6,9,12-octadecatrienoic acid + [16] |
Target- |
Action modulators |
Mechanism Immunomodulators |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date Australia (15 Jul 1994), |
Regulation- |
Molecular FormulaC18H30O2 |
InChIKeyVZCCETWTMQHEPK-QNEBEIHSSA-N |
CAS Registry506-26-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D07213 | Gamolenic acid |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dermatitis, Atopic | Australia | - | 15 Jul 1994 |
Mastodynia | Hungary | - | - |
Mastodynia | Mexico | - | - |
Mastodynia | Switzerland | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 2 | United Kingdom | - | - |
Rheumatoid Arthritis | Clinical | United States | - | - |